González-García Samuel, Hamdan-Partida Aida, Pérez-Ramos Julia, Aguirre-Garrido José Félix, Bustos-Hamdan Anaíd, Bustos-Martínez Jaime
Doctorado en Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana, Mexico City, Mexico.
Departamento de Atención a la Salud, UAM Xochimilco, Calzada del Hueso 1100, Colonia Villa Quietud, Alcaldía Coyoacán, C.P. 04960, CDMX, Mexico.
J Med Microbiol. 2024 Dec;73(12). doi: 10.1099/jmm.0.001940.
is a bacterium that colonizes various human sites. The pharynx has been considered as a site of little clinical relevance and little studied. Recently, it has been reported that can colonize more the pharynx than the nose. In addition, can persist in these sites for prolonged periods of time. The composition of the pharyngeal and nasal microbiome will differ between persistent, intermittent carriers and non-carriers of . Determine whether the pharyngeal and nasal microbiome is different between carriers and non-carriers of . carriers were monitored by means of pharyngeal and nasal exudates of apparently healthy adult university students for 3 months. Samples from individuals of the same carrier type were pooled, and DNA was extracted and the 16S rRNA was sequenced. The sequences were analysed in MOTHUR v.1.48.0 software, by analysing the percentages of relative abundance in the STAMP 2.1.3 program, in addition to the predictive analysis of metabolic pathways in PICRUSt2. A greater colonization of was found in the pharynx than in the nose. The microbiomes of carriers and non-carriers do not show significant differences. The main microbiome difference found was between pharyngeal and nasal microbiomes. No significant differences were found in the abundance of the genus in pharyngeal and nasal carriers and non-carriers. The nasal microbiome was found to have more variation compared to the pharyngeal microbiome, which appears to be more stable between individuals and pools. Predictive analysis of metabolic pathways showed a greater presence of -associated pathways in the nose than in the pharynx. can colonize and persist in the pharynx in equal or greater proportion than in the nose. No statistically significant differences were found in the microbiome of the pharyngeal and nasal carriers and non-carriers of , but the pharyngeal and nasal microbiomes are different independent of the type of carrier or non-carrier. Therefore, the microbiome apparently does not influence the persistence of .
是一种定殖于人体多个部位的细菌。咽一直被认为是临床相关性不大且研究较少的部位。最近有报道称,它在咽部的定殖比在鼻部更多。此外,它能在这些部位长期持续存在。在持续性、间歇性携带者以及非携带者中,咽部和鼻部微生物群的组成会有所不同。确定携带者和非携带者之间咽部和鼻部微生物群是否存在差异。通过对表面健康的成年大学生的咽部分泌物和鼻部分泌物进行3个月的监测来观察携带者。将相同携带者类型个体的样本合并,提取DNA并对16S rRNA进行测序。在MOTHUR v.1.48.0软件中对序列进行分析,除了在PICRUSt2中对代谢途径进行预测分析外,还在STAMP 2.1.3程序中分析相对丰度百分比。发现它在咽部的定殖比在鼻部更多。携带者和非携带者的微生物群没有显示出显著差异。发现的主要微生物群差异存在于咽部和鼻部微生物群之间。在咽部和鼻部携带者及非携带者中,该属的丰度没有发现显著差异。发现鼻微生物群相比咽微生物群有更多变异,咽微生物群在个体和样本库之间似乎更稳定。代谢途径的预测分析表明,与该细菌相关的途径在鼻部比在咽部更多。它在咽部定殖和持续存在的比例与在鼻部相等或更高。在该细菌的咽部和鼻部携带者及非携带者的微生物群中未发现统计学上的显著差异,但无论是否携带该细菌,咽部和鼻部微生物群都是不同的。因此,微生物群显然不影响该细菌的持续存在。